Retatrutide – 15 mg Vial

Retatrutide is a synthetic multi-receptor agonist peptide studied in research environments for its interaction with key metabolic and energy-regulation signaling pathways. It is commonly explored for activity across GLP-1, GIP, and glucagon receptor pathways, making it a focal peptide in advanced metabolic and endocrine research models.

The 15 mg format is often selected for mid-length or flexible research protocols that require additional peptide availability beyond entry-level formats while maintaining consistency in formulation and purity.

Product Details

• Peptide: Retatrutide

• Concentration: 15 mg per vial

• Form: Lyophilized powder

• Packaging: Sterile, sealed glass vial

Key Research Areas of Interest

• Metabolic and energy balance signaling pathways

• GLP-1, GIP, and glucagon receptor research

• Endocrine and glucose metabolism studies

• Body composition and metabolic regulation research

Research Findings Indicate Potential Associations With:

• Appetite and satiety signaling research

• Energy expenditure and metabolic efficiency pathways

• Body composition and weight-regulation studies

• Glucose and insulin signaling research models

Quality & Standards

• Manufactured for research and educational purposes only

• Produced under strict quality and purity standards

• Third-party testing available upon request

• Stored and shipped to preserve peptide stability and integrity

Important Notice

This product is not approved for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.